Anti D 300mcg Injection is indicated to prevent infections. It prevents antibodies from forming after a person with Rh-negative blood receives a transfusion with Rh-positive blood, or during pregnancy when a mother has Rh-negative blood and the baby is Rh-positive. Anti D 300mcg Injection is given for Rh prophylaxis in pregnancy-related complications. It is also approved for Incompatible transfusions in Rh-negative individuals transfused with blood components containing Rh-positive red blood cells (RBCs). It may also be used for immune thrombocytopenic purpura, a condition wherein the number of circulating platelets decrease leading to easy bruising. Your doctor or nurse will give you this injection. Kindly do not self administer. The injection is given into a muscle; normally it is given in the upper arm. You will be offered an anti-D injection routinely at 28 weeks of pregnancy and within 72 hours of birth if your baby is Rh D positive.

Zyrop 5000IU injection contains active components such as Recombinant human erythropoietin alfa/epoetin alfa. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). This medication treats anemia caused by chronic kidney disease (CKD), cancer chemotherapy, or HIV infection treatment with zidovudine. It also reduces the need for red blood cell transfusions in patients at high risk for blood loss due to planned surgery or other procedures. Zyrop 5000IU injection should not be used in patients with hypersensitivity to it or any of its components, uncontrolled hypertension, active thrombotic microangiopathy (TMA), pure red cell aplasia (PRCA), uncontrolled seizures, pregnancy, or lactation. It should also be used cautiously in patients with a history of blood clots, heart disease, stroke, kidney disease, liver disease, thalassemia, sickle cell anemia, myelodysplastic syndrome, leukemia, or cancer. It should only be used in children under 18 if the benefits outweigh the risks. Older adults taking this medication should be closely monitored for side effects. Before starting this medication, it is important to talk to your doctor about the risks and benefits of Zyrop 5000IU injection.

Erypro safe 4000IU injection contains active components such as Recombinant human erythropoietin alfa/epoetin alfa. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). This medication treats anemia caused by chronic kidney disease (CKD), cancer chemotherapy, or HIV infection treatment with zidovudine. It also reduces the need for red blood cell transfusions in patients at high risk for blood loss due to planned surgery or other procedures. Erypro safe 4000IU injection should not be used in patients with hypersensitivity to it or any of its components, uncontrolled hypertension, active thrombotic microangiopathy (TMA), pure red cell aplasia (PRCA), uncontrolled seizures, pregnancy, or lactation. It should also be used cautiously in patients with a history of blood clots, heart disease, stroke, kidney disease, liver disease, thalassemia, sickle cell anemia, myelodysplastic syndrome, leukemia, or cancer. It should only be used in children under 18 if the benefits outweigh the risks. Older adults taking this medication should be closely monitored for side effects. Before starting this medication, it is important to talk to your doctor about the risks and benefits of Erypro safe 4000IU injection.

Erypro safe 10000IU injection contains active components such as Recombinant human erythropoietin alfa/epoetin alfa. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). This medication treats anemia caused by chronic kidney disease (CKD), cancer chemotherapy, or HIV infection treatment with zidovudine. It also reduces the need for red blood cell transfusions in patients at high risk for blood loss due to planned surgery or other procedures. Erypro safe 10000IU injection should not be used in patients with hypersensitivity to it or any of its components, uncontrolled hypertension, active thrombotic microangiopathy (TMA), pure red cell aplasia (PRCA), uncontrolled seizures, pregnancy, or lactation. It should also be used cautiously in patients with a history of blood clots, heart disease, stroke, kidney disease, liver disease, thalassemia, sickle cell anemia, myelodysplastic syndrome, leukemia, or cancer. It should only be used in children under 18 if the benefits outweigh the risks. Older adults taking this medication should be closely monitored for side effects. Before starting this medication, it is important to talk to your doctor about the risks and benefits of Erypro safe 10000IU injection.

CPM Injection refers to Chlorpheniramine Maleate Injection, a first-generation antihistamine commonly used in clinical settings to manage allergic reactions and related conditions. It is available in various strengths, such as 4 mg, 10 mg, and 20 mg per vial, and is administered via intravenous (IV) or intramuscular (IM) injection. ________________________________________ 🩺 Medical Uses CPM Injection is employed to treat a range of allergic and hypersensitivity conditions, including: • Acute Allergic Reactions: Such as anaphylaxis, where rapid intervention is crucial. • Chronic Allergies: Including hay fever, allergic rhinitis, and conjunctivitis. • Skin Conditions: Like urticaria (hives), angioedema (swelling), and pruritus (itching). • Pre-Medication: Administered before blood transfusions or certain medications to prevent allergic reactions. • Motion Sickness: To alleviate symptoms associated with nausea and vomiting. • Common Cold Symptoms: Such as sneezing and runny nose. Its rapid onset makes it particularly valuable in emergency and hospital settings. ________________________________________ ⚙️ Mechanism of Action Chlorpheniramine Maleate works by blocking histamine receptors (H1 receptors) in the body. Histamine is a chemical involved in allergic responses; by inhibiting its action, CPM reduces symptoms like itching, swelling, and redness. ________________________________________ 💉 Administration and Dosage CPM Injection is administered by healthcare professionals: • Intravenous (IV) Injection: For rapid onset of action. • Intramuscular (IM) Injection: For sustained release and longer duration of effect. The dosage and frequency depend on the specific condition being treated, the patient's age, weight, and overall health status. It is crucial to follow the prescribing healthcare provider's instructions. ________________________________________ ⚠️ Precautions and Contraindications Before administering CPM Injection, inform the healthcare provider if the patient has: • Allergy: To chlorpheniramine or any other antihistamines. • Medical Conditions: Such as glaucoma, high blood pressure, or gastrointestinal issues. • Pregnancy or Breastfeeding: Discuss potential risks and benefits. CPM may cause drowsiness; therefore, activities requiring alertness, like driving, should be avoided during treatment. Alcohol consumption should also be limited, as it can exacerbate drowsiness. ________________________________________ ⚠️ Side Effects Common side effects may include: • Drowsiness or sedation. • Dizziness or lightheadedness. • Dry mouth. • Blurred vision. • Nausea or vomiting. If any side effects persist or worsen, consult a healthcare provider promptly.